Jose H. Bedoya - 08 Feb 2024 Form 4 Insider Report for SURMODICS INC (SRDX)

Role
Director
Signature
/s/ John Manders, on behalf of Jose H. Bedoya
Issuer symbol
SRDX
Transactions as of
08 Feb 2024
Net transactions value
-$31.66
Form type
4
Filing time
12 Feb 2024, 16:18:16 UTC
Previous filing
13 Feb 2023
Next filing
18 Feb 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SRDX Common Stock Options Exercise $94,171 +3,932 +15% $23.95 30,108 08 Feb 2024 Direct
transaction SRDX Common Stock Tax liability $94,203 -2,954 -9.8% $31.89 27,154 08 Feb 2024 Direct
transaction SRDX Common Stock Award $0 +1,803 +6.6% $0.000000 28,957 08 Feb 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SRDX Stock Option (right to buy) Options Exercise $0 -3,932 -100% $0.000000* 0 08 Feb 2024 Common Stock 3,932 $23.95 Direct F2
transaction SRDX Stock Option (right to buy) Award $0 +3,853 $0.000000 3,853 08 Feb 2024 Common Stock 3,853 $31.89 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The amount beneficially owned includes 15,772 restricted stock units (RSUs) that vest on service-based vesting dates and 8,430 DSUs that are vested upon issuance, each of which will be settled in shares of the issuer's common stock on a 1 for 1 basis when the reporting person's service as a director ends.
F2 Fully vested.
F3 The stock options vest ratably on a monthly basis and become fully vested on February 8, 2025, the 12-month anniversary of the grant date.